New Key Statistics Module, Z-Score and F-Score
OTCPK:CASIF Key Ratios
| Market Cap $ M | 3.04 |
| Enterprise Value $ M | 24.90 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 0.13 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 20.00 |
| EPS (TTM) $ | -2.58 |
| Beneish M-Score | -11.99 |
| 10-y EBITDA Growth Rate % | -0.80 |
| 5-y EBITDA Growth Rate % | 4.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.55 |
| EV-to-EBITDA | -0.55 |
| PEG | -- |
| Shares Outstanding M | 20.56 |
| Net Margin (%) | -232.00 |
| Operating Margin % | -206.84 |
| Pre-tax Margin (%) | -221.47 |
| Quick Ratio | 0.24 |
| Current Ratio | 0.27 |
| ROA % (ttm) | -136.66 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -124.30 |
| Dividend Yield % | -- |
| Altman Z-Score | -47.49 |
CASIF Number of Guru Trades
CASIF Volume of Guru Trades
Gurus Latest Trades with OTCPK:CASIF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CASIF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CASI Pharmaceuticals Inc Insider Transactions
No Available Data
News about OTCPK:CASIF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers